VEXAS综合征的眼眶/眼部炎症受累:来自国际AIDA网络VEXAS登记处的数据
该研究基于国际AIDA网络VEXAS登记处59例患者,27例(45.8%)在临床病程中出现眼眶/眼部炎症受累,以眶周水肿8例(13.6%)最常见。复发性多软骨炎与眼眶/眼部受累显著相关(相对危险度2.37,95%CI 1.03-5.46,p=0.048)。全队列中位病程1.2年(IQR=5.35)内发生6例死亡,其中5例(83.3%)有眼眶/眼部炎症受累。
要点
- 59例VEXAS患者中27例(45.8%)出现眼眶/眼部炎症受累,眶周水肿最常见(8例,13.6%)。
- 复发性多软骨炎与眼眶/眼部受累显著相关(相对危险度2.37,95%CI 1.03-5.46,p=0.048)。
- 全队列6例死亡中5例(83.3%)有眼眶/眼部炎症受累,作者认为这类患者可能需要更密切随访。
核心结论
- 本研究证实眼眶/眼部炎症受累是VEXAS患者的常见表现,尤其在诊断为复发性多软骨炎时。
- 作者认为这使眼科医生成为VEXAS综合征诊断过程中的关键角色。
- 本研究中观察到的死亡高频次似乎提示有眼眶/眼部受累的患者可能需要更多关注和更仔细的随访。
研究设计与样本
- 基于国际AIDA网络VEXAS登记处的描述性研究,纳入59例VEXAS患者,分析其临床病史中眼眶/眼部炎症表现及与其他疾病表现的相关性。
主要发现
- 59例VEXAS患者中27例(45.8%)在临床病史中出现眼眶/眼部炎症受累。
- 最常见的眼眶/眼部病变为眶周水肿8例(13.6%)、巩膜外层炎5例(8.5%)、巩膜炎5例(8.5%)、葡萄膜炎4例(6.8%)、结膜炎4例(6.8%)、睑缘炎3例(5.1%)、眼眶肌炎2例(3.4%)。
- 15例(55.6%)诊断为系统性免疫介导疾病,其中12例诊断为复发性多软骨炎。
- 复发性多软骨炎与VEXAS综合征眼眶/眼部受累显著相关(相对危险度2.37,95%CI 1.03-5.46,p=0.048)。
- 全队列在中位病程1.2年(IQR=5.35)内观察到6例死亡,其中5例(83.3%)有眼眶/眼部炎症受累。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
VEXAS syndrome is a recently described monogenic autoinflammatory disease capable of manifesting itself with a wide array of organs and tissues involvement. Orbital/ocular inflammatory manifestations are frequently described in VEXAS patients. The objective of this study is to further describe orbital/ocular conditions in VEXAS syndrome while investigating potential associations with other disease manifestations. In the present study, twenty-seven out of 59 (45.8 %) VEXAS patients showed an inflammatory orbital/ocular involvement during their clinical history. The most frequent orbital/ocular affections were represented by periorbital edema in 8 (13.6 %) cases, episcleritis in 5 (8.5 %) patients, scleritis in 5 (8.5 %) cases, uveitis in 4 (6.8 %) cases, conjunctivitis in 4 (6.8 %) cases, blepharitis in 3 (5.1 %) cases, orbital myositis in 2 (3.4 %) cases. A diagnosis of systemic immune-mediated disease was observed in 15 (55.6 %) cases, with relapsing polychondritis diagnosed in 12 patients. A significant association was observed between relapsing polychondritis and orbital/ocular involvement in VEXAS syndrome (Relative Risk: 2.37, 95 % C.I. 1.03-5.46, p = 0.048). Six deaths were observed in the whole cohort of patients after a median disease duration of 1.2 (IQR=5.35) years, 5 (83.3 %) of which showed orbital/ocular inflammatory involvement. In conclusion, this study confirms that orbital/ocular inflammatory involvement is a common finding in VEXAS patients, especially when relapsing polychondritis is diagnosed. This makes ophthalmologists a key figure in the diagnostic process of VEXAS syndrome. The high frequency of deaths observed in this study seems to suggest that patients with orbital/ocular involvement may require increased attention and more careful follow-up.
引用
- Vitale A, Caggiano V, Martin-Nares E, et al. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry. Semin Arthritis Rheum. 2024. PMID: 38554594. doi:10.1016/j.semarthrit.2024.152430
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。